Bone mineral density in children with juvenile chronic arthritis
- PMID: 9890693
- DOI: 10.1007/BF01451301
Bone mineral density in children with juvenile chronic arthritis
Abstract
The aim of this study was to evaluate bone mineral density changes in patients with juvenile chronic arthritis (JCA) and to determine the most likely causes of osteoporosis in these patients. Eighteen (11 male, 7 female) patients suffering from JCA and 14 healthy controls (10 male, four female) were included in this study. The mean age of the patients and control groups were 11.0 +/- 3.2 and 10.9 +/- 2.9 years respectively. Disease activity was determined by clinical and laboratory evaluation and 'Articular Disease Severity Score' (ADSS). Bone mineral density (BMD) of the femoral neck and lumbar spine was measured by dual photon absorptiometry. BMD of the patients at the lumbar spine was significantly lower than the control group (p < 0.05). This difference was more marked in patients treated with steroids. Femoral neck BMD was also lower in the patient group but this difference was not statistically significant. There was a negative correlation between ADSS and BMD at the spine. In conclusion, trabecular bone loss is characteristic for osteoporosis in JCA. Our results indicate that steroid treatment and disease severity are important factors in the development of osteoporosis in JCA.
Similar articles
-
Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis.Rheumatol Int. 2003 May;23(3):127-9. doi: 10.1007/s00296-002-0265-0. Epub 2003 Mar 12. Rheumatol Int. 2003. PMID: 12739043
-
Evaluation by dual X-ray absorptiometry (DXA) of bone mineral density in children with juvenile chronic arthritis.Clin Exp Rheumatol. 1998 Jul-Aug;16(4):495-501. Clin Exp Rheumatol. 1998. PMID: 9706436
-
Development of bone mineral density at the lumbar spine and femoral neck in juvenile chronic arthritis--a prospective one year followup study.J Rheumatol. 1998 Dec;25(12):2450-5. J Rheumatol. 1998. PMID: 9858444
-
Effects of rheumatic disease and corticosteroid treatment on calcium metabolism and bone density in children assessed one year after diagnosis, using stable isotopes and dual energy x-ray absorptiometry.J Rheumatol Suppl. 2000 Apr;58:38-43. J Rheumatol Suppl. 2000. PMID: 10782855 Review.
-
Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management.Int J Mol Sci. 2022 May 20;23(10):5725. doi: 10.3390/ijms23105725. Int J Mol Sci. 2022. PMID: 35628529 Free PMC article. Review.
Cited by
-
Bone mineral status in children with congenital adrenal hyperplasia.J Pediatr Endocrinol Metab. 2007 Feb;20(2):227-35. doi: 10.1515/jpem.2007.20.2.227. J Pediatr Endocrinol Metab. 2007. PMID: 17396440 Free PMC article.
-
Osteoporosis.Curr Rheumatol Rep. 2001 Oct;3(5):365-70. doi: 10.1007/s11926-996-0005-7. Curr Rheumatol Rep. 2001. PMID: 11564366 Review.
-
Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases.Clin Rheumatol. 2008 Jul;27(7):909-12. doi: 10.1007/s10067-008-0864-6. Epub 2008 Mar 11. Clin Rheumatol. 2008. PMID: 18330609
-
Glucocorticoid-induced osteoporosis in rheumatic diseases.Clinics (Sao Paulo). 2010;65(11):1197-205. doi: 10.1590/s1807-59322010001100024. Clinics (Sao Paulo). 2010. PMID: 21243296 Free PMC article. Review.
-
Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders.Arthritis Care Res (Hoboken). 2010 Apr;62(4):516-26. doi: 10.1002/acr.20171. Arthritis Care Res (Hoboken). 2010. PMID: 20391507 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous